2062. Misbranding of B-I-F Combination.    U. S. v. 39 Cartons of B-I-F Com 
bination (and 1 otber seizure action against B-I-F Combination). De- 
fault decrees of condemnation and destruction. (F. D. C. Nos. 19962, 
20236.    Sample Nos. 156-H, 41900-H.)
LIBELS FILED: May 28 and June 13, 1946, Southern District of Florida and 
Eastern District of North Carolina. t
ALLEGED SHIPMENT : On or about October 19, 1945, and February 25 and March 
8,1946, by W. C. Hughes & Co., Inc., from Baltimore, Md.
PRODUCT : B-I-F ComUnation. 39 cartons, each containing 2 bottles, at Tampa, 
Fla., and 41 cartons, each containing 2 bottles, at Wilmington, N. C. One of 
the bottles in each of the cartons contained an emulsion, and the other bottle 
contained an injection preparation.
LABEL, m PAST: (Carton) "B-I-F Combination Emulsion contains: Balsam 
Copaiba Oil Cassia, U. S. P. Potassium Hydroxide, U. S. P. Powdered 
Acacia, U. S. P. Sugar Glycerin, U. S. P. Injection contains: Zinc Acetate, 
U. S. P. Carbolic Acid, U. S. P. Glycerin, U. S. P. Caramel"; (both bottles) 
"Purchasers wishing to avoid attention in the use of this article, are advised 
to place the bottle in water a few moments after which this label can readily 
be removed"; (leaflet enclosed in some cartons) "B-I-F Combination An 
Emulsion (For Internal Use) An Injection (With Syringe) Directions 
Shake the bottle containing the Injection which is red, fill the syringe full, and 
inject the contents slowly into the urinal passage, holding the syringe in the 
right hand. Allow the medicine to remain 20 to 30 seconds. The Emulsion, 
which is white, should be taken internally three times a day, before meals, 
in teaspoonful doses, in the morning on arising, at noon and at bedtime. The 
injection should be used about the same time, and always after passing water."
NATURE OF CHARGE: Misbranding, Section 502 (a), the labeling of the article 
was false and misleading since it represented and created the impression that 
the article, when taken as directed, would be effective in the treatment of 
gonorrhea, whereas the article would not be effective for such purpose; and, 
Section 502 (f) (1), the labeling of the portion of the article which did not 
contain the leaflet failed to bear adequate directions for use.
DISPOSITION: August 7 and November 25, 1946. No claimant having apeared, 
judgments of condemnation were entered and the product was ordered 
destroyed.